Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (FY)Sep 30, 2024 | (FY)Sep 30, 2023 | (FY)Sep 30, 2022 | |
|---|---|---|---|---|
| Total revenue | 17.78%3.36B | 42.08%2.85B | 52.36%2.01B | 1.32B |
| Cost of revenue | -7.30%829.72M | -4.45%895.06M | 32.43%936.72M | 707.32M |
| Gross profit | 29.25%2.53B | 82.76%1.96B | 75.45%1.07B | 610.54M |
| Operating expense | 21.64%2.24B | 8.65%1.84B | 24.27%1.69B | 1.36B |
| Operating profit | 149.79%290.4M | 118.64%116.26M | 17.21%-623.72M | -753.34M |
| Net non-operating interest income (expenses) | 16.19%-20.87M | 42.14%-24.9M | -177.07%-43.04M | -15.53M |
| Non-operating interest income | 1,975.90%4.05M | 1,118.75%195K | 77.78%16K | --9K |
| Non-operating interest expense | -22.95%18.42M | -11.84%23.9M | 107.06%27.11M | --13.09M |
| Total other finance cost | 442.37%6.5M | -92.48%1.2M | 550.82%15.95M | --2.45M |
| Net investment income | ||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||
| Income from associates and other participating interests | ||||
| Special income (charges) | -52.81%109K | 102.82%231K | -335.39%-8.19M | -1.88M |
| Less:Other special charges | 52.81%-109K | ---231K | ---- | --1.38M |
| Less:Write off | ---- | --0 | 1,522.57%8.19M | --505K |
| Other non-operating income (expenses) | -161.25%-11.09M | 13.39%-4.24M | -302.35%-4.9M | 2.42M |
| Income before tax | 196.02%258.56M | 112.85%87.34M | 11.52%-679.86M | -768.34M |
| Income tax | 185.78%83.25M | -18,410.00%-97.04M | -76.86%530K | 2.29M |
| Net income | -4.92%175.31M | 127.10%184.39M | 11.71%-680.39M | -770.63M |
| Net income continuous operations | -4.92%175.31M | 127.10%184.39M | 11.71%-680.39M | ---770.63M |
| Noncontrolling interests | ||||
| Net income attributable to the company | -4.92%175.31M | 127.10%184.39M | 11.71%-680.39M | -770.63M |
| Preferred stock dividends | ||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -4.92%175.31M | 127.10%184.39M | 11.71%-680.39M | -770.63M |
| Gross dividend payment | ||||
| Basic earnings per share | -54.74%14.31 | 127.10%31.6206 | -75.77%-116.6798 | -66.3808 |
| Diluted earnings per share | -57.50%13.44 | 127.10%31.6206 | -75.77%-116.6798 | -66.3808 |
| Dividend per share | ||||
| Currency Unit | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |